At the news
? NEUTRALIMPACT 2/10 6-K filed Aug 10, 2026 at 12:18 ET
Dr. Reddy's terminated a distribution and promotion agreement with Novartis India Limited (NIL) due to a change in NIL's controlling shareholding. The company will continue commercializing the affected brands until September 30, 2026. This is a routine operational update with no material financial impact disclosed.
- Terminated agreement dated February 11, 2022 with Novartis India Limited for distribution and promotion of select brands in India.
- Termination follows a change in controlling shareholding of Novartis India Limited.
- Dr. Reddy's will continue to commercialize the brands until September 30, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access